A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder
PHASE3
Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...
A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug
PHASE4
The purpose of this study is to compare the patient satisfaction between co...
A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia
PHASE4
The purpose of this study is to compare the effect of oral paliperidone ext...
A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia
PHASE1
The purpose of this study is a noninferiority comparison of the orthostatic...